1. Home
  2. BNL vs TLX Comparison

BNL vs TLX Comparison

Compare BNL & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$17.50

Market Cap

3.3B

Sector

Real Estate

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$8.05

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNL
TLX
Founded
2007
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNL
TLX
Price
$17.50
$8.05
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$19.86
$21.00
AVG Volume (30 Days)
1.9M
169.8K
Earning Date
10-29-2025
01-15-2026
Dividend Yield
6.63%
N/A
EPS Growth
N/A
N/A
EPS
0.47
0.04
Revenue
$447,973,000.00
$664,225,558.00
Revenue This Year
$5.83
N/A
Revenue Next Year
$7.20
N/A
P/E Ratio
$37.30
$249.18
Revenue Growth
5.49
55.35
52 Week Low
$13.96
$7.72
52 Week High
$18.87
$30.36

Technical Indicators

Market Signals
Indicator
BNL
TLX
Relative Strength Index (RSI) 44.95 33.92
Support Level $17.25 $7.72
Resistance Level $17.91 $8.22
Average True Range (ATR) 0.27 0.25
MACD 0.01 -0.07
Stochastic Oscillator 38.30 13.42

Price Performance

Historical Comparison
BNL
TLX

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: